共 50 条
Novel Insights into Chk1 Regulation by Phosphorylation
被引:19
|作者:
Goto, Hidemasa
[1
,2
]
Kasahara, Kousuke
[1
,3
]
Inagaki, Masaki
[1
,2
]
机构:
[1] Aichi Canc Ctr Res Inst, Div Biochem, Nagoya, Aichi 4648681, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Cellular Oncol, Nagoya, Aichi 4668550, Japan
[3] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Oncol, Nagoya, Aichi 4678603, Japan
基金:
日本学术振兴会;
关键词:
Chk1;
cell-cycle checkpoint;
phosphorylation;
CELL-CYCLE CHECKPOINT;
DNA-DAMAGE CHECKPOINT;
EARLY EMBRYONIC LETHALITY;
PREMATURE MITOTIC ENTRY;
KINASE;
CANCER-THERAPY;
REPLICATION STRESS;
MEDIATED PHOSPHORYLATION;
PROTEIN PHOSPHATASE;
HEMATOPOIETIC-CELLS;
D O I:
10.1247/csf.14017
中图分类号:
Q2 [细胞生物学];
学科分类号:
071009 ;
090102 ;
摘要:
Checkpoint kinase 1 (Chk1) is a conserved protein kinase central to the cell-cycle checkpoint during DNA damage response (DDR). Until recently, ATR, a protein kinase activated in response to DNA damage or stalled replication, has been considered as the sole regulator of Chk1. Recent progress, however, has led to the identification of additional protein kinases involved in Chk1 phosphorylation, affecting the subcellular localization and binding partners of Chk1. In fact, spatio-temporal regulation of Chk1 is of critical importance not only in the DDR but also in normal cell-cycle progression. In due course, many potent inhibitors targeted to Chk1 have been developed as anticancer agents and some of these inhibitors are currently in clinical trials. In this review, we summarize the current knowledge of Chk1 regulation by phosphorylation.
引用
收藏
页码:43 / 50
页数:8
相关论文